Medication assistance task force: stakeholders and chair

The brief names seven perspectives — prescribers, discharge planners, financial navigators, patients, suppliers, book keepers and subsidizers — and then asks you to invite five to seven stakeholders. That gap is deliberate. If you may invite fewer than the perspectives listed, you must decide which ones are essential to designing a medication assistance program and which can be consulted without holding a seat. So do not simply assign one invitee per listed perspective and call it a proposal. Argue the cut. A financial navigator and a book keeper both bring money to the table, but one understands what a patient can access and the other understands what the organisation can sustain; deciding whether you need both is exactly the judgement the CEO is asking for. Whichever you drop, say why, and say how their input will still reach the group through consultation, written submission or a later review round.

The patient seat deserves particular attention because it is the one most often included as a gesture. A medication assistance program exists to remove a barrier that patients experience and administrators infer, so a patient or patient advocate who has actually navigated cost-related non-adherence brings information nobody else at the table has. Say what that person contributes specifically. The facilitator question is separate and the brief flags it deliberately: a facilitator manages the process rather than the content, which usually means someone without a stake in the outcome, so nominating the person with the strongest opinion about the program is the wrong answer. Then follow the structure the brief dictates exactly — a paragraph of purpose, one paragraph per invited stakeholder, and a close stating what you hope to accomplish within a designated time frame. Give an actual timeframe, with milestones, rather than saying the group will work efficiently.